Quantcast

Latest ZIOPHARM Oncology Inc. Stories

2014-06-23 12:28:46

LONDON, June 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Global Testicular Cancer Drugs Market 2014-2018http://www.reportbuyer.com/pharma_healthcare/therapeutic/global_testicular_cancer_drugs_market_2014_2018.html TechNavio's analysts forecast the Global Testicular Cancer Drugs market to grow at a CAGR of 4.02 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing incidence of testicular...

2010-04-21 06:30:00

NEW YORK, April 21 /PRNewswire/ -- The Kristen Ann Carr Fund has awarded a grant to Jonathan Lewis, MD, PhD, Chief Executive Officer and Chief Medical Officer of ZIOPHARM Oncology, Inc., which will fund translational work at the Memorial Sloan-Kettering Cancer Center and the Albert Einstein College of Medicine in New York City, for the development of a novel treatment for pediatric sarcoma. The competitive grant was established to honor the 70th birthday of Murray F. Brennan, MD, Chairman...

2008-11-05 09:00:34

ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that Jonathan Lewis, MD, PhD, Chief Executive and Medical Officer, will present at the Rodman & Renshaw 10th Annual Healthcare Conference on Tuesday, November 11, 2008 at 4:30 pm ET at the New York Palace Hotel in New York City. Dr. Lewis will provide an overview of the Company and its clinical development programs. The presentation will be webcast live and can be accessed by visiting the Investor Relations section at...

2008-11-03 09:00:39

ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that the Company will host an analyst and institutional investor meeting on Thursday, November 20, 2008 from 7:30 A.M. to 10:00 A.M. Eastern Time in New York City. The event will be moderated by Jonathan Lewis, MD, PhD, Chief Executive Officer of ZIOPHARM and will include an in-depth discussion of the Company's product pipeline and clinical development strategy. The presentation will feature other members of the ZIOPHARM management...

2008-10-31 09:00:28

ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today its financial results for the three and nine-month period ending September 30, 2008. The Company reported a lower net loss for the third quarter of 2008 of $5.5 million, or $(0.26) per share, compared with a net loss for the third quarter of 2007 of $7.3 million, or $(0.35) per share. Total operating expenses for the quarter were $5.6 million, compared with $7.9 million for the same quarter in the prior year. The decrease was...

2008-10-27 09:00:41

ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that Jonathan Lewis, MD, PhD, Chief Executive and Medical Officer, will present at the Oppenheimer & Co. 19th Annual Healthcare Conference on Monday, November 3, 2008 at 3:20 pm ET at the Waldorf-Astoria Hotel in New York City. Dr. Lewis will provide an overview of the Company and its clinical development programs. The presentation will be webcast live and can be accessed by visiting the Investor Relations section at...

2008-10-23 09:00:10

ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP), announced today that it presented darinaparsin (ZIO-101) mechanism of action data as well as preliminary data from Phase I studies with oral administration at the 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Geneva, Switzerland. Data from preclinical studies on the molecular mechanism of action of darinaparsin were presented demonstrating that darinaparsin is highly active in a series of cell lines including those...

2008-10-15 09:00:47

ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP), announced today that the European Medicines Agency's (EMEA) Committee for Orphan Medicinal Products (COMP) has issued a positive opinion regarding ZIOPHARM's application for orphan medicinal product designation for palifosfamide in the treatment of soft tissue sarcoma (STS). In the European Union (EU), products targeted to treat life-threatening or very serious conditions that affect fewer than five in 10,000 people are eligible for orphan...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related